Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Laminin 5 expression in metaplastic breast carcinomas.

Carpenter PM, Wang-Rodriguez J, Chan OT, Wilczynski SP.

Am J Surg Pathol. 2008 Mar;32(3):345-53. doi: 10.1097/PAS.0b013e3181592201. Erratum in: Am J Surg Pathol. 2009 Feb;33(2):322.

PMID:
18300817
2.

Metaplastic breast carcinomas and their relationship with basal-like phenotype.

Cakir A, Gönül II, Uluoğlu O.

Turk Patoloji Derg. 2012;28(2):134-41. doi: 10.5146/tjpath.2012.01112.

3.

Expression of p40 and laminin 332 in metaplastic spindle cell carcinoma of the breast compared with other malignant spindle cell tumours.

D'Alfonso TM, Ross DS, Liu YF, Shin SJ.

J Clin Pathol. 2015 Jul;68(7):516-21. doi: 10.1136/jclinpath-2015-202923.

PMID:
25795733
4.

Metaplastic breast carcinoma: pathology and clinical outcome.

Bellino R, Arisio R, D'Addato F, Attini R, Durando A, Danese S, Bertone E, Grio R, Massobrio M.

Anticancer Res. 2003 Jan-Feb;23(1B):669-73.

PMID:
12680165
5.

Diagnostic utility of snail in metaplastic breast carcinoma.

Nassar A, Sookhan N, Santisteban M, Bryant SC, Boughey JC, Giorgadze T, Degnim A.

Diagn Pathol. 2010 Nov 26;5:76. doi: 10.1186/1746-1596-5-76.

6.

Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity [corrected]. .

Weigelt B, Ng CK, Shen R, Popova T, Schizas M, Natrajan R, Mariani O, Stern MH, Norton L, Vincent-Salomon A, Reis-Filho JS.

Mod Pathol. 2015 Mar;28(3):340-51. doi: 10.1038/modpathol.2014.142. Erratum in: Mod Pathol. 2015 Apr;28(4):607.

7.

Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.

Grenier J, Soria JC, Mathieu MC, Andre F, Abdelmoula S, Velasco V, Morat L, Besse B, Dunant A, Spielmann M, Delaloge S.

Anticancer Res. 2007 Jan-Feb;27(1B):547-55.

8.

The majority of triple-negative breast cancer may correspond to basal-like carcinoma, but triple-negative breast cancer is not identical to basal-like carcinoma.

Kuroda N, Ohara M, Inoue K, Mizuno K, Fujishima N, Hamaguchi N, Lee GH.

Med Mol Morphol. 2009 Jun;42(2):128-31. doi: 10.1007/s00795-008-0428-5.

PMID:
19536621
9.

p63 is useful in the diagnosis of mammary metaplastic carcinomas.

Tse GM, Tan PH, Chaiwun B, Putti TC, Lui PC, Tsang AK, Wong FC, Lo AW.

Pathology. 2006 Feb;38(1):16-20.

PMID:
16484002
10.

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.

Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, Perou CM.

Mod Pathol. 2006 Feb;19(2):264-71.

11.

Metaplastic breast carcinomas are enriched in markers of tumor-initiating cells and epithelial to mesenchymal transition.

Zhang Y, Toy KA, Kleer CG.

Mod Pathol. 2012 Feb;25(2):178-84. doi: 10.1038/modpathol.2011.167.

13.

Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.

Dabbs DJ, Chivukula M, Carter G, Bhargava R.

Mod Pathol. 2006 Nov;19(11):1506-11.

14.
15.
16.

Laminin 332 expression in breast carcinoma.

Kwon SY, Chae SW, Wilczynski SP, Arain A, Carpenter, Philip M.

Appl Immunohistochem Mol Morphol. 2012 Mar;20(2):159-64. doi: 10.1097/PAI.0b013e3182329e8f.

17.

Increased alpha-B-crystallin expression in mammary metaplastic carcinomas.

Chan SK, Lui PC, Tan PH, Yamaguchi R, Moriya T, Yu AM, Shao MM, Hliang T, Wong SI, Tse GM.

Histopathology. 2011 Aug;59(2):247-55. doi: 10.1111/j.1365-2559.2011.03882.x.

PMID:
21884203
18.

Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue.

Reis-Filho JS, Steele D, Di Palma S, Jones RL, Savage K, James M, Milanezi F, Schmitt FC, Ashworth A.

Mod Pathol. 2006 Feb;19(2):307-19.

19.

p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma.

Koker MM, Kleer CG.

Am J Surg Pathol. 2004 Nov;28(11):1506-12.

PMID:
15489655
20.
Items per page

Supplemental Content

Support Center